Skip to Content


In the US, Brevibloc (esmolol systemic) is a member of the following drug classes: cardioselective beta blockers, group II antiarrhythmics and is used to treat Atrial Fibrillation, Atrial Flutter, High Blood Pressure, Intra- or Post-op SVT or Hypertension and Supraventricular Tachycardia.

US matches:

Ingredient matches for Brevibloc


Esmolol is reported as an ingredient of Brevibloc in the following countries:

  • Cyprus
  • Italy
  • Switzerland

Esmolol hydrochloride (a derivative of Esmolol) is reported as an ingredient of Brevibloc in the following countries:

  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Japan
  • Malta
  • Netherlands
  • Norway
  • Pakistan
  • Poland
  • Slovenia
  • Spain
  • Sweden
  • Taiwan
  • Turkey
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.